OTC:BRGX | Cash Flow Statement | BIOREGENX, INC.

Complete source-backed cash-flow history.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31-$26,415.00$12,943.00$26,629.00-$50,206.00
2025-12-31-$1.02M$69,636.00$3,057.00-$3,057.00-$44,143.00
2025-09-30-$80,565.00
2025-06-30-$178,345.00
2025-03-31-$266,854.00$12,377.00$37,695.00$0.00$0.00-$10,415.00
2024-12-31-$18.4M$2.2M-$11,361.00$0.00$2,652.00-$6,944.00
2024-09-30-$394,860.00$12,377.00
2024-06-30-$1.11M$7,642.00
2024-03-31-$3.15M-$104,250.00$189,390.00-$190,597.00$282,562.00
2023-12-31-$256,748.00-$245,626.00$0.00-$199,363.00$513,370.00
2023-09-30-$2.52M$1,193.00
2023-06-30-$594,461.00$1,194.00
2023-03-31-$548,033.00-$566.00$0.00-$110.00
2022-12-31-$5,535.00-$4,364.00$0.00$3,499.00
2022-09-30-$2,191.00
2022-06-30-$33,263.00
2022-03-31-$37,319.00-$20,920.00$0.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$1.54M$75,075.00$38,972.00$9,057.00-$59,057.00$33,098.00
2024-12-31-$23.05M$2.22M-$324,148.00$189,390.00-$187,945.00$442,119.00
2023-12-31-$3.6M-$1.52M$0.00-$199,363.00$1.2M
2022-12-31-$78,308.00-$64,652.00$0.00$40,970.00
2021-12-31-$96,873.00-$119,517.00$0.00$50,000.00